Bibliografía del artículo
1. Parkin DM, Bray FI, Devesa SS. Cancer burden in year 2000:The global picture. Eur J Cancer 37(Suppl.):S4-66, 2001.
2. Smith EB, Frierson HF Jr, Mills SE, Boyd JC, Theodorescu D. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading? Cancer 94:2282-2287, 2002.
3. Moussa AS, Li J, Soriano M, Klein EA, Dong F, Jones JS. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer. BJU Int 103:43-48, 2009.
4. Yoo C, Oh C, Cho J, et al. Clinical Significance of a Large Difference u2265 2 points between Biopsy and Post-prostatectomy Pathological Gleason Scores in Patients with Prostate Cancer. J Korean Med Sci 26:507-512, 2011.
5. Gomez-Ferrer A, Arlandis S. Analisis de imagen asistido or ordendor en ecografia transrectal de prostata. Actas Urol Esp 35:404-413, 2011.
6. Grossklaus DJ, Coffey CS, Shappell SB, et al. Prediction of tumour volumen and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores. BJU Int 88:722-726, 2001.
7. Obek C, Louis P, Civantos F, et al. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol 161:494-498, 1999.
8. Gohji K, Okamoto M, Takenaka A, et al. Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate-specific antigen in Japanese men. BJU Int 83:39-42, 1999.
9. González-Enguita C, Fernández-Aceñero MJ, García-Cardoso JV, López-Pérez L, Manzarbeitia F, Vela-Navarrete R. Relación entre el volumen de la glándula prostática y algunos marcadores histológicos de malignidad. Actas Urol Esp 36:86-90, 2012.
10. Jager GJ, Severens JL, Thronbury JR, et al. Prostate cancer staging: Should MR Imaging be used? A decision analytic approach. Radiology 215:445-451, 2000.
11. Rorvik J, Halvorsen OJ, Albrektsen G, et al. MRI with an endorectal coil for staging of clinically localizad prostate cancer prior to radical prostatectomy. Eur Radiol 9:29-34, 1999.
12. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic Imaging- clinicopathologic study. Radiology 213:473-480, 1999.
13. Gregori A, Vieweg J, Dahm P, et al. Comparison of ultrasound-guided biopsias and prostatectomy specimens: Predictive accuracy of Gleason score and tumour site. Urol int 66:66-71, 2001.
14. Fütterer J, Engelbrecht M, Huisman H, et al. Staging Prostate Cancer with Dynamic Contrast-enhanced Endorectal MR Imaging prior to Radical Prostatectomy: Experienced versus Less Experienced Readers. Radiology 237:541-549, 2005.
15. Köksal IT, Ozcan F, Kadioglu TC, Esen T, Kiliçaslan I, Tunç M. Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens. Eur Urol 37:670-674, 2000.
16. Zakian K, Sircar K, Hricak H, et al. Correlation of Proton MR Spectroscopic Imaging with Gleason Score Based on Step-Section Pathologic Analysis after Radical Prostatectomy. Radiology 234:804-814, 2005.
17. Latouf JB, Saad F. Gleason score on biopsy: is it reliable for predicting the final grade on pathology? BJU Int 90:694-699, 2001.
18. Shukla-Dave A, Hricak H, Kattan MW, et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int 99:786-793, 2007.
19. Baker MJ, Gazi E, Broen MD, et al FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer. British Journal of Cancer 99:1859-1866, 2008.
20. Gazi E, Baker M, Dwyer J, et al. A correlation of FTIR spectra derived form prostate cancer biopsias with Gleason grade and tumour stage. Eur Urol 50:750-761, 2006.
21. Umbegr M, Bachmann L, Held U, et al. Combined magnetic resonante Imaging and magnetic resonante spectroscopy Imaging in the diagnosis of prostate cancer: systematic review and meta-analysis. Eur Urol 55:575-591, 2009.
22. Cornud F, Bellin MF, Portalez D. IRM etbilan d´extension du cancer de la prostate. J Radiol 87:228-45, 2006.
23. Rouviere O, Hartman RP, Lyon D, et al . Prostate RM Imaging at high field strenght: evolution or revolution? Eur Radiol 16:276-84, 2006.
24. Novis M, Baroni R, Mendes L, et al. Clinically low-risk prostate cancer: evaluation with transrectal doppler ultrasound and functional magnetic resonance Imaging. Clinics 66(1):27-34, 2011.